메뉴 건너뛰기




Volumn 15, Issue 21, 2014, Pages 9355-9360

New formulated "DOX-MTX-loaded nanoparticles" downregulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: The effect of IV and oral modalities

Author keywords

DOX MTX NPs; HER2; Oral and IV route; Oral squamous cell carcinoma(OSCC)

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; MESSENGER RNA; METHOTREXATE; NANOPARTICLE;

EID: 84918535635     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.21.9355     Document Type: Article
Times cited : (13)

References (35)
  • 1
    • 85047687395 scopus 로고    scopus 로고
    • Expression of EGFR and p53 in head and neck tumors among sudanese patients
    • Abusail M, Dirweesh AM, Salih RA, et al (2013). Expression of EGFR and p53 in head and neck tumors among sudanese patients. Asian Pac J Cancer Prev, 14, 6415-8.
    • (2013) Asian Pac J Cancer Prev , vol.14 , pp. 6415-6418
    • Abusail, M.1    Dirweesh, A.M.2    Salih, R.A.3
  • 2
    • 79954486971 scopus 로고    scopus 로고
    • Drug delivery systems using polymer nanoassemblies for cancer treatment
    • Bae Y (2010). Drug delivery systems using polymer nanoassemblies for cancer treatment. Ther Deliv, 1, 361-3.
    • (2010) Ther Deliv , vol.1 , pp. 361-363
    • Bae, Y.1
  • 3
    • 84880296848 scopus 로고    scopus 로고
    • Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancers
    • Baykara M, Buyukberber S, Ozturk B, et al (2013). Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancers. Asian Pac J Cancer Prev, 14, 2557-61.
    • (2013) Asian Pac J Cancer Prev , vol.14 , pp. 2557-2561
    • Baykara, M.1    Buyukberber, S.2    Ozturk, B.3
  • 4
    • 33846363943 scopus 로고    scopus 로고
    • Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity?
    • Bell R, Kademani D, Homer L, et al (2007). Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity? J Oral Maxillofac Surg, 65, 229-36.
    • (2007) J Oral Maxillofac Surg , vol.65 , pp. 229-236
    • Bell, R.1    Kademani, D.2    Homer, L.3
  • 5
    • 84856510684 scopus 로고    scopus 로고
    • Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability
    • Benival D, PV D (2012). Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability. Int J Pharm, 423, 554-61.
    • (2012) Int J Pharm , vol.423 , pp. 554-561
    • Benival, D.P.V.D.1
  • 6
    • 12844278687 scopus 로고    scopus 로고
    • Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival
    • Brandwein-Gensler M, Teixeira MS, Lewis CM, et al (2005). Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol, 29, 167-78.
    • (2005) Am J Surg Pathol , vol.29 , pp. 167-178
    • Brandwein-Gensler, M.1    Teixeira, M.S.2    Lewis, C.M.3
  • 7
    • 84896395527 scopus 로고    scopus 로고
    • Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. current and emerging paradigms
    • Cipriani P, Ruscitti P, Carubbi F, et al (2014). Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. current and emerging paradigms. Clin Ther, 36, 427-35.
    • (2014) Clin Ther , vol.36 , pp. 427-435
    • Cipriani, P.1    Ruscitti, P.2    Carubbi, F.3
  • 8
    • 84877694815 scopus 로고    scopus 로고
    • The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics
    • Deng Y, Zhang H (2013). The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics. Int J Nanomedicine, 8, 1835-41.
    • (2013) Int J Nanomedicine , vol.8 , pp. 1835-1841
    • Deng, Y.1    Zhang, H.2
  • 9
    • 84884159175 scopus 로고    scopus 로고
    • Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment
    • Duong HH, Yung LY (2013). Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment. Int J Pharm, 454, 486-95.
    • (2013) Int J Pharm , vol.454 , pp. 486-495
    • Duong, H.H.1    Yung, L.Y.2
  • 10
    • 17644385184 scopus 로고    scopus 로고
    • Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat
    • Gibson RJ, Bowen JM, Cummins AG, et al (2005). Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat. Clin Exp Med, 4, 188-95.
    • (2005) Clin Exp Med , vol.4 , pp. 188-195
    • Gibson, R.J.1    Bowen, J.M.2    Cummins, A.G.3
  • 11
    • 78650317418 scopus 로고    scopus 로고
    • Nanoparticle-assisted combination therapies for effective cancer treatment
    • Hu CM, Aryal S, Zhang L (2010). Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv, 1, 323-34.
    • (2010) Ther Deliv , vol.1 , pp. 323-334
    • Hu, C.M.1    Aryal, S.2    Zhang, L.3
  • 12
    • 78751591177 scopus 로고    scopus 로고
    • Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2
    • Huang WY, Yang PM, Chang YF, et al (2011). Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. Biochem Pharmacol, 81, 510-7.
    • (2011) Biochem Pharmacol , vol.81 , pp. 510-517
    • Huang, W.Y.1    Yang, P.M.2    Chang, Y.F.3
  • 13
    • 83755229569 scopus 로고    scopus 로고
    • The possible impact of obesity on androgen, progesterone and estrogen receptors (ERa and ERb) gene expression in breast cancer patients
    • Jahanban Esfahlan R, Zarghami N, Jahanban Esfahlan A, et al (2011a). The possible impact of obesity on androgen, progesterone and estrogen receptors (ERa and ERb) gene expression in breast cancer patients. Breast Cancer (Auckl), 227-37.
    • (2011) Breast Cancer (Auckl) , pp. 227-237
    • Jahanban Esfahlan, R.1    Zarghami, N.2    Jahanban Esfahlan, A.3
  • 14
    • 84906215850 scopus 로고    scopus 로고
    • Quantification of steroid receptors gene expression in breast cancer patients: possible correlation with serum level of adipocytokines
    • Jahanban Esfahlan R, Zarghami N, Rahmati-Yamchi M, et al (2011b). Quantification of steroid receptors gene expression in breast cancer patients: possible correlation with serum level of adipocytokines. J Cancer Therapy, 2, 659-65.
    • (2011) J Cancer Therapy , vol.2 , pp. 659-665
    • Jahanban Esfahlan, R.1    Zarghami, N.2    Rahmati-Yamchi, M.3
  • 15
    • 84885745424 scopus 로고    scopus 로고
    • Adiponectin can affect er signaling in obese breast cancer patients
    • Jahanban Esfahlan R, Zarghami N, Valiyari S, et al (2012). Adiponectin can affect er signaling in obese breast cancer patients. J Cancer Therapy, 3, 115-21.
    • (2012) J Cancer Therapy , vol.3 , pp. 115-121
    • Jahanban Esfahlan, R.1    Zarghami, N.2    Valiyari, S.3
  • 16
    • 0026751470 scopus 로고
    • Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity. arch.otolaryngol
    • Jones KR, Lodge-Rigal RD, Reddick RL, et al (1992). Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity. arch.otolaryngol. Head Neck Surg, 118, 483-5.
    • (1992) Head Neck Surg , vol.118 , pp. 483-485
    • Jones, K.R.1    Lodge-Rigal, R.D.2    Reddick, R.L.3
  • 17
    • 27344445891 scopus 로고    scopus 로고
    • Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade
    • Kademani D, Bell RB, Bagheri S, et al (2005). Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg, 63, 1599-605.
    • (2005) J Oral Maxillofac Surg , vol.63 , pp. 1599-1605
    • Kademani, D.1    Bell, R.B.2    Bagheri, S.3
  • 18
    • 60049090585 scopus 로고    scopus 로고
    • Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats
    • Kalaria DR, Sharma G, Beniwal V, et al (2009). Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm Res, 26, 492-501.
    • (2009) Pharm Res , vol.26 , pp. 492-501
    • Kalaria, D.R.1    Sharma, G.2    Beniwal, V.3
  • 19
    • 84903934867 scopus 로고    scopus 로고
    • Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
    • Khademi B, Khademi B, Ghaderi A, et al (2013). Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma. Iran J Otorhinolaryngol, 25, 161-8.
    • (2013) Iran J Otorhinolaryngol , vol.25 , pp. 161-168
    • Khademi, B.1    Khademi, B.2    Ghaderi, A.3
  • 20
    • 0034798128 scopus 로고    scopus 로고
    • Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ
    • Kim HR, Christensen R, Park NH, et al (2001). Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ. Clin Cancer Res, 7, 3079-86.
    • (2001) Clin Cancer Res , vol.7 , pp. 3079-3086
    • Kim, H.R.1    Christensen, R.2    Park, N.H.3
  • 21
    • 84903541520 scopus 로고    scopus 로고
    • Role of concomitant chemoradiation in locally advanced head and neck cancers
    • Lasrado S, Moras K, GJ P, et al (2014). Role of concomitant chemoradiation in locally advanced head and neck cancers. Asian Pac J Cancer Prev, 15, 4147-52.
    • (2014) Asian Pac J Cancer Prev , vol.15 , pp. 4147-4152
    • Lasrado, S.1    Moras, K.G.J.P.2
  • 22
    • 0026919991 scopus 로고
    • erb-B oncogene in human oral squamous cell carcinomas
    • Li B, Wang M, Wen Y, et al (1992). [erb-B oncogene in human oral squamous cell carcinomas]. Hua Xi Yi Ke Da Xue Xue Bao, 23, 284-7.
    • (1992) Hua Xi Yi Ke Da Xue Xue Bao , vol.23 , pp. 284-287
    • Li, B.1    Wang, M.2    Wen, Y.3
  • 23
    • 0035953705 scopus 로고    scopus 로고
    • Molecular markers of the risk of oral cancer
    • Lippman SM, Hong WK (2001). Molecular markers of the risk of oral cancer. N Engl J Med, 344, 1323-6.
    • (2001) N Engl J Med , vol.344 , pp. 1323-1326
    • Lippman, S.M.1    Hong, W.K.2
  • 25
    • 84906214439 scopus 로고    scopus 로고
    • Evaluation of the effect of two systemic doses of HESA-A on prevention of induced tongue neoplasm in rats
    • Mehdipour M, Taghavi ZA, Mesgari AM, et al (2013). Evaluation of the effect of two systemic doses of HESA-A on prevention of induced tongue neoplasm in rats. J Dent Res Dent Clin Dent Prospects, 7, 218-24.
    • (2013) J Dent Res Dent Clin Dent Prospects , vol.7 , pp. 218-224
    • Mehdipour, M.1    Taghavi, Z.A.2    Mesgari, A.M.3
  • 26
    • 84908376977 scopus 로고    scopus 로고
    • DOX-MTX-NPs augment p53 mRNA expression in OSCCs model in rat: the effect of IV and oral dosages
    • Mesgari Abbasi M, Monfaredan A, Hamishehkar H, et al (2014b). DOX-MTX-NPs augment p53 mRNA expression in OSCCs model in rat: the effect of IV and oral dosages. Asian Pac J Cancer Prev, 19, 8377-82.
    • (2014) Asian Pac J Cancer Prev , vol.19 , pp. 8377-8382
    • Mesgari Abbasi, M.1    Monfaredan, A.2    Hamishehkar, H.3
  • 27
    • 84906240948 scopus 로고    scopus 로고
    • Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities
    • Mesgari Abbasi M, Monfaredan A, Hamishehkar H, et al (2014d). Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities. Asian Pac J Cancer Prev, 15, 6227-32.
    • (2014) Asian Pac J Cancer Prev , vol.15 , pp. 6227-6232
    • Mesgari Abbasi, M.1    Monfaredan, A.2    Hamishehkar, H.3
  • 28
    • 66949147316 scopus 로고    scopus 로고
    • Prognostic factors in squamous cell carcinoma of the oral cavity
    • Montoro JR, Ricz HA, Souza L, et al (2008). Prognostic factors in squamous cell carcinoma of the oral cavity. Braz J Otorhinolaryngol, 74, 861-6.
    • (2008) Braz J Otorhinolaryngol , vol.74 , pp. 861-866
    • Montoro, J.R.1    Ricz, H.A.2    Souza, L.3
  • 29
    • 77949419636 scopus 로고    scopus 로고
    • Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis
    • Rossi B, Schinzari G, Maccauro G, et al (2010). Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis. BMC Musculoskelet Disord, 11, 34.
    • (2010) BMC Musculoskelet Disord , vol.11 , pp. 34
    • Rossi, B.1    Schinzari, G.2    Maccauro, G.3
  • 30
    • 84898402598 scopus 로고    scopus 로고
    • Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs
    • Salehi R, Hamishehkar H, Eskandani M, et al (2014). Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs. J Drug Target, 22, 327-42.
    • (2014) J Drug Target , vol.22 , pp. 327-342
    • Salehi, R.1    Hamishehkar, H.2    Eskandani, M.3
  • 31
    • 84874044271 scopus 로고    scopus 로고
    • HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated
    • Sardari Y, Pardis S, Tadbir AA, et al (2012). HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated. Asian Pac J Cancer Prev, 13, 2891-6.
    • (2012) Asian Pac J Cancer Prev , vol.13 , pp. 2891-2896
    • Sardari, Y.1    Pardis, S.2    Tadbir, A.A.3
  • 32
    • 0037864294 scopus 로고    scopus 로고
    • Prognostic relevance of molecular markers of oral cancer-a review
    • Schliephake H (2003). Prognostic relevance of molecular markers of oral cancer-a review. Int J Oral Maxillofac Surg, 32, 233-45.
    • (2003) Int J Oral Maxillofac Surg , vol.32 , pp. 233-245
    • Schliephake, H.1
  • 33
    • 84871711842 scopus 로고    scopus 로고
    • Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
    • Tacar O, Sriamornsak P, Dass CR (2013). Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol, 65, 157-70.
    • (2013) J Pharm Pharmacol , vol.65 , pp. 157-170
    • Tacar, O.1    Sriamornsak, P.2    Dass, C.R.3
  • 34
    • 79955042843 scopus 로고    scopus 로고
    • Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects
    • Wang Y, Wei X, Zhang C, et al (2010). Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects. Ther Deliv, 1, 273-87.
    • (2010) Ther Deliv , vol.1 , pp. 273-287
    • Wang, Y.1    Wei, X.2    Zhang, C.3
  • 35
    • 8544219695 scopus 로고    scopus 로고
    • Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate
    • Yoo HS, Park TG (2004). Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release, 100, 247-56.
    • (2004) J Control Release , vol.100 , pp. 247-256
    • Yoo, H.S.1    Park, T.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.